Synopsys/$SNPS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Synopsys
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
- Ticker
- $SNPS
- Sector
- Software & Cloud Services
- Primary listing
- NASDAQ
- Employees
- 28,000
- Headquarters
- Sunnyvale, United States
- Website
- www.synopsys.com
Synopsys Metrics
BasicAdvanced
$83B
76.41
$5.64
1.18
-
Price and volume
Market cap
$83B
Beta
1.18
52-week high
$539.48
52-week low
$362.55
Average daily volume
2M
Financial strength
Current ratio
1.337
Quick ratio
1.166
Long term debt to equity
0.311
Total debt to equity
0.348
Interest coverage (TTM)
1.66%
Profitability
EBITDA (TTM)
2,075.486
Gross margin (TTM)
82.92%
Net profit margin (TTM)
11.43%
Operating margin (TTM)
11.03%
Effective tax rate (TTM)
17.17%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
1.35%
Return on equity (TTM)
3.66%
Valuation
Price to earnings (TTM)
76.405
Price to revenue (TTM)
8.68
Price to book
2.65
Price to tangible book (TTM)
-11.56
Price to free cash flow (TTM)
29.748
Free cash flow yield (TTM)
3.36%
Free cash flow per share (TTM)
14.485
Growth
Revenue change (TTM)
46.33%
Earnings per share change (TTM)
-55.49%
3-year revenue growth (CAGR)
22.40%
10-year revenue growth (CAGR)
14.76%
3-year earnings per share growth (CAGR)
-5.35%
10-year earnings per share growth (CAGR)
13.66%
What the Analysts think about Synopsys
Analyst ratings (Buy, Hold, Sell) for Synopsys stock.
Analyst projections of the future price of Synopsys stock.
Bulls say / Bears say
Synopsys beat its third-quarter guidance and raised its 2026 revenue and earnings outlook, pointing to improving execution across the business. (Synopsys)
Demand for chip-design tools is benefiting from AI investment and the growing complexity of advanced chips. Reuters also reported that major technology companies are stepping up in-house chip programmes, creating another source of demand for Synopsys. (Reuters)
The Ansys combination could create new growth through integrated chip-design and simulation products. Synopsys says its Multiphysics Fusion solution has been validated by customers and is expected to start contributing to EDA growth in 2027. (The Motley Fool)
Synopsys’ 2026 outlook assumes no further changes to export controls. Tighter restrictions could limit sales or delay customer work, particularly in China. (Synopsys)
The Ansys acquisition leaves Synopsys with roughly $10 billion of debt, while the company still needs to deliver the deal’s expected benefits. That debt and integration burden could constrain flexibility if growth or synergies disappoint. (Investing.com, Synopsys)
An August analysis put Synopsys’ price-to-earnings ratio at 77.5, leaving the shares exposed to a sharp re-rating if growth falls short of expectations. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 28 Oct 2026.
Synopsys Financial Performance
Revenues and expenses
Synopsys Earnings Performance
Company profitability
Upcoming events
No upcoming events
Synopsys News
AllArticlesVideos
Funds containing Synopsys
AllUSDEURGBP
Fund name | Fund size | $SNPS weighting |
|---|---|---|
VanEck Quantum Computing€QUTM | $751M | 5.72% |
Vaneck Quantum Computing£QNTG | $751M | 5.72% |
iShares Quantum Computing£QANT | $73M | 2.47% |
WisdomTree Artificial Intelligence€WTAI | €996M | 2.28% |
WisdomTree Artificial Intelligence£INTL | £870M | 2.28% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.


